Package 51662-1484-1

Brand: glycopyrrolate

Generic: glycopyrrolate
NDC Package

Package Facts

Identity

Package NDC 51662-1484-1
Digits Only 5166214841
Product NDC 51662-1484
Product ID 51662-1484_2b397d13-8372-9f3f-e063-6294a90ac9ca
Description

20 mL in 1 VIAL (51662-1484-1)

Marketing

Marketing Status
Marketed Since 2020-01-11
Brand glycopyrrolate
Generic glycopyrrolate
Sample Package No

Linked Drug Pages (1)

GLYCOPYRROLATE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "2b397d13-8372-9f3f-e063-6294a90ac9ca", "openfda": {"unii": ["V92SO9WP2I"], "rxcui": ["238212"], "spl_set_id": ["9bde90dd-0300-f705-e053-2a95a90a7ea6"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "20 mL in 1 VIAL (51662-1484-1)", "package_ndc": "51662-1484-1", "marketing_start_date": "20200111"}], "brand_name": "GLYCOPYRROLATE", "product_id": "51662-1484_2b397d13-8372-9f3f-e063-6294a90ac9ca", "dosage_form": "INJECTION", "pharm_class": ["Anticholinergic [EPC]", "Cholinergic Antagonists [MoA]", "Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "51662-1484", "generic_name": "GLYCOPYRROLATE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GLYCOPYRROLATE", "active_ingredients": [{"name": "GLYCOPYRROLATE", "strength": ".2 mg/mL"}], "application_number": "ANDA090963", "marketing_category": "ANDA", "marketing_start_date": "20200111", "listing_expiration_date": "20261231"}